Combined immunization against meningococcal disease and human papillomavirus
AssigneeSanofi Pasteur Limited
InventorsRichard David Kensinger, Jr., Steven L. Hauser, Emilia Ivanova Jordanov, Mandeep Singh Dhingra, David Neveu
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds, compositions, formulations, kits, uses, and methods for immunization against Neisseria meningitidis serogroups A, C, Y, and W-135 and human papilloma virus.
Claims17
A method of immunization against Neisseia meningitidis serogroups A, C, Y, and W-135 and human papilloma virus (HPV) without interference with the development of immunity against one or more types of HPV including HPV type 18, the method comprising coadministering a Neisseria meningitidis vaccine composition and an HPV Type 18 L1 protein to a subject in need thereof, wherein the Neisseia meningitidis vaccine composition comprises:
- a) a first conjugate of MenA capsular polysaccharide to tetanus toxoid;
- b) a second conjugate of MenC capsular polysaccharide to tetanus toxoid;
- c) a third conjugate of MenW-135 capsular polysaccharide to tetanus toxoid;
- and
- d) a fourth conjugate of MenY capsular polysaccharide to tetanus toxoid;
- and wherein the administration of the Neisseia meningitidis vaccine composition does not interfere with the development of immunity against HPV Type 18.
Dependencies are inferred from the claim text.